Article
Association of Primary Prophylactic (PP) Granulocyte-colony Stimulating Factor (G-CSF) Use with Chemotherapy Dose Modifications and Relative Dose Intensity (RDI) Among Breast Cancer Patients Receiving High-risk Regimens for Febrile Neutropenia (FN)
Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Quality Care Symposium
(2021)
Abstract
J. Shaw; J. Schenfeld; A. Balasubramanian; R. Jaramillo; D. Sandchafer; M. Kelsh
Disciplines
Publication Date
September 21, 2021
Citation Information
Reshma Mahtani. "Association of Primary Prophylactic (PP) Granulocyte-colony Stimulating Factor (G-CSF) Use with Chemotherapy Dose Modifications and Relative Dose Intensity (RDI) Among Breast Cancer Patients Receiving High-risk Regimens for Febrile Neutropenia (FN)" Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Quality Care Symposium Vol. 39 Iss. 28_suppl. (2021) Available at: http://works.bepress.com/reshma-mahtani/53/